Evidence that mCPP may have behavioural effects mediated by central 5‐HT1C receptors

British Journal of Pharmacology

Volumn 94, Issue 1, 1988, Pages 137-147

  Kennett, G A ^a   Curzon, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 5 HYDROXYTRYPTOPHAN; CARBIDOPA; CYANOPINDOLOL; CYPROHEPTADINE; IDAZOXAN; KETANSERIN; MESULERGINE; METERGOLINE; MIANSERIN; PINDOLOL; PROPRANOLOL; RITANSERIN; SEROTONIN 1C RECEPTOR; SEROTONIN RECEPTOR; SPIPERONE; TROPISETRON;

ANIMAL EXPERIMENT; BEHAVIOR; FEEDING; GROOMING; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PSYCHOLOGICAL ASPECT; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BEHAVIOR, ANIMAL; DRUG INTERACTIONS; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; RATS; RATS, INBRED STRAINS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0023894791     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1988.tb11508.x     Document Type: Article

References (46)

1. Neuroendocrine and behavioural effects of m‐chlorophenylpiperazine administration in rhesus monkeys
2. 1B heterogeneity
3. ‘Wet dog’ shake behaviour in the rat: a possible quantitative model of central 5‐hydroxytryptamine activity
4. Appetite stimulating properties of cyproheptadine
5. Serotonin and appetite
6. 3H‐5‐hydroxytryptamine in the rat CNS
7. Proposals for the classification and nomenclature of functional receptors for 5‐hydroxytryptamine
8. Plasma concentration of trazodone and 1‐(3‐chlorphenyl)piperazine in man after a single oral dose of trazodone
9. Serotonin function in anxiety II. Effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects
10. 2‐receptors in the CNS: studies with mianserin
11. 3H] mesulergine, a selective ligand for serotonin‐2 receptors
12. 1B binding sites
13. 125Iodo]‐cyanopindolol, a new ligand for adrenoceptors: identification and quantitation of subclasses of α‐adrenoceptors in guinea pig
14. Trazodone, a triazolopyridine derivative in primary depressive disorder
15. Trazodone in the treatment of neurotic depression
16. The behavioural effects of RU 24969, a suggested 5‐HT, receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants
17. 1B receptor binding sites in brain?
18. Characterization of a novel 3H‐5‐Hydroxytryptamine binding site subtype in bovine brain membranes
19. Mianserin in out patients with depressive illness in dosage up to 130 mg daily
20. 3H] ketanserin
21. Effects of m‐chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats
22. 1C receptors
23. 1B agonists induce anorexia at a postsynaptic site
24. Receptor binding profile of R41 468, a novel antagonist of 5‐HT2 receptors
25. 2 antagonist
26. Behavioural effects of indole and piperazine type serotonin receptor agonists
27. 1 recognition site
28. Comparative pharmacology of mianserin, its main metabolites and 6‐azamianserin
29. The 5‐HT syndrome in rats as a tool for the screening of psychoactive drugs
30. The binding of serotoninergic ligands to the porcine choroid plexus; characterization of a new type of serotonin recognition site
31. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin‐1 receptors
32. 3H] 5‐hydroxytryptamine binding sites by neuroleptic spiperone in rat brain
33. 3H] spiroperidol
34. A double‐blind multi‐centre trial comparing the efficacy and side effects of mianserin and clomipramine in depressed in‐patients and out patients
35. Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity
36. Identification of serotonin m‐receptor subtypes and their specific blockade by a new class of drugs
37. m‐chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats
38. 2‐adrenoceptors in the regulation of striatal dopaminergic transmission
39. 3 receptor antagonists ICS 205–930 and MDL 72222 on 5‐HTP‐induced head shaking and behavioural symptoms induced by 5‐methoxy‐N,N‐dimethyltrypt‐amine in rats: comparison with some other 5‐HT receptor antagonists
40. 1B receptor subtypes in rat frontal cortex
41. Trazodone and m‐chlorophenyl‐piperazine; concentration in brain and receptor activity in regions in the brain associated with anxiety
42. Tricyclic antidepressant drug interactions with histamine and α‐adrenergic receptors
43. 1 receptor and of catecholaminergic systems in the behavioural response to 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin in the rat
44. 1 receptor agonist RU 24969 in the rat